If you’ve been following the buzz in the health and wellness world, chances are you’ve heard of GLP-1 agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Initially developed to manage type 2 diabetes, these medications have now emerged as groundbreaking tools in the fight against overweight and obesity.

Insulin resistance means that the cells in the body have become less responsive to insulin, which leads to elevated insulin and blood sugar levels. This leads to more belly fat, hunger/cravings, and fatigue - and if left unchecked, can lead to type 2 diabetes, cardiovascular disease, and even many cancers. That’s why it’s critical to take insulin resistance seriously.